PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-53.98%
Negative net income growth while AVGO stands at 18.46%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
14.71%
D&A growth well above AVGO's 0.14%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-315.66%
Negative yoy deferred tax while AVGO stands at 3.83%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
13.77%
SBC growth while AVGO is negative at -13.92%. John Neff would see competitor possibly controlling share issuance more tightly.
152.99%
Well above AVGO's 3.75% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
242.55%
AR growth is negative or stable vs. AVGO's 575.00%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
52.00%
Inventory shrinking or stable vs. AVGO's 480.70%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-790.38%
Both negative yoy AP, with AVGO at -160.25%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
852.17%
Some yoy usage while AVGO is negative at -77.35%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
23.08%
Some yoy increase while AVGO is negative at -5.88%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
84.39%
Operating cash flow growth above 1.5x AVGO's 2.48%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-35.33%
Negative yoy CapEx while AVGO is 14.29%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
65.21%
Purchases well above AVGO's 100.00%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-61.79%
Both yoy lines are negative, with AVGO at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-34.15%
Both yoy lines negative, with AVGO at -90.70%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-81.74%
Both yoy lines negative, with AVGO at -151.43%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
60.00%
We repay more while AVGO is negative at -2032.17%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
-262.00%
We cut yoy buybacks while AVGO is 39.92%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.